Search
Quince Therapeutics Inc
QNCXAdd to Watchlist
29.360USD
+2.640+9.88%
Close 10-08 16:00（ET）
28.77MMarket Cap
1.30P/E TTM
Quince Therapeutics Inc (QNCX) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Quince Therapeutics Inc in the past month.
Buy
2 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
75.429USD+158.32%
QNCX Analyst Recommendation Trends
In the current month, QNCX has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QNCX average Analyst price target in the last month is 75.429.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
1
0
0
0
0
1
3
2
2
0
0
0
0
0
0
3
3
3
3
3
3
4
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
5
7
6
3
4
4
4
6
Financial Forecasting
Based on analysts' estimates, QNCX EPS is projected to reach -3.594 in FY2026Q3, following reported EPS of -12.309 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-37.76
-51.20
-17.88
-3.59
-3.72
Actual
-7.09
78.75
-12.31
--
--
Surprise
+81.23%
+253.81%
+31.16%
--
--
FAQs
What is Quince Therapeutics Inc's price target?
Analysts forecast that Quince Therapeutics Inc's price target is USD 8.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 4.00.
How have Quince Therapeutics IncQNCX's recent earnings per share performed?
The market expectation was USD -12.31, while Quince Therapeutics IncQNCX's earnings per share (EPS) for the previous quarter was USD 78.75. EPS for the next quarter is expected at USD -3.59.
What is the analyst rating for Quince Therapeutics Inc?
Based on the ratings of Quince Therapeutics Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.